Optical microprobe for blood clot detection

• US 20080300493A1
• Filed: 06/06/2008
• Published: 12/04/2008
• Est. Priority Date: 12/07/2005
• Status: Abandoned Application

• Current Assignee: Board of Trustees of The University of Illinois
• Original Assignee: Board of Trustees of The University of Illinois
• Inventors: Charbel, Fady, Gratton, Enrico, D'amico, Enrico, Mantulin, William W., Gatto, Rodolfo
• Application Number:
  US12/134,757
• Publication Number:
  US 20080300493A1
• Time in Patent Office: Days
• US Class Current: 600/479
• CPC Class Codes: A61B 17/22 Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for dilators A61M29/00
• CPC Class Codes: A61B 2017/00778 Operations on blood vessels A61B2017/22097, A61B2017/320741 take precedence
• CPC Class Codes: A61B 2090/306 using optical fibres
• CPC Class Codes: A61B 2090/3614 using optical fibre
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/0086 using infrared radiation
• CPC Class Codes: A61B 5/02007 Evaluating blood vessel condition, e.g. elasticity, compliance
• CPC Class Codes: A61B 90/36 Image-producing devices or illumination devices not otherwise provided for
• CPC Class Codes: A61B 90/37 Surgical systems with images on a monitor during operation

Abstract

The invention is devices and related methods for detecting blood clots in a blood vessel. An optical microprobe is configured to illuminate a blood vessel with electromagnetic radiation corresponding to the near-infrared portion of the electromagnetic spectrum. The optical microprobe has a pair of fiber optic strands configured for transmission spectroscopy to obtain the absorption spectrum generated by the components within the blood vessel. Because blood clots generate a detectable and unique spectrum, the presence or absence of the blood clot is determined by examining the blood vessel absorption spectrum. A specially-designed holder is configured to stably position the optical microprobe relative to the blood vessel and is used to facilitate precise blood clot detection along a length of blood vessel.

Claims

1. An optical microprobe for non-invasively detecting blood clots in a blood vessel by transmission spectroscopy, said optical microprobe comprising:

a. an optical source for generating electromagnetic radiation having a wavelength range corresponding to the wavelength of near infrared light and capable of being absorbed by a blood clot;

b. a first fiber optic strand capable of transmitting the electromagnetic radiation generated by the optical source, the strand having a proximal end and a distal end, wherein the proximal end is optically connected to the optical source, and the distal end is capable of illuminating the blood vessel with the electromagnetic radiation;

c. a second fiber optic strand capable of transmitting the electromagnetic radiation generated by the optical source, the strand having a proximal end and a distal end, wherein the distal end is capable of collecting the electromagnetic radiation that has illuminated and passed through the blood vessel; and

d. a holder having a first holding arm connected to the first fiber optic strand distal end and a second holding arm connected to the second fiber optic strand distal end, wherein the holder stably positions the distal portions of the first and second fiber optic strands in a diametrically opposed configuration and separated by a separation distance.

2. The optical microprobe of claim 1 wherein each of the holding arms has a bottom end, the optical microprobe further comprising:

a. a first holding tip connected to the first holding arm bottom end; and

b. a second holding tip connected to the second holding arm bottom,

wherein, the first holding tip is connected to the distal end of the first fiber optic strand, and the second holding tip is connected to the distal end of the second fiber optic strand.

3. The optical microprobe of claim 2, wherein the holding tip further comprises an orifice, and the distal end of the fiber optic strand is disposed within the orifice.

4. The optical microprobe of claim 1, further comprising means for selecting the separation distance.

5. The optical microprobe of claim 4, wherein the separation distance is selected from a range of about 0.5 mm to about 2 cm.

6. The optical microprobe of claim 1, further comprising a micromanipulator connected to the holder for controllable positioning of the distal ends of the fiber optic strands.

7. The optical microprobe of claim 1, further comprising an optical detector optically connected to the second fiber optic strand proximal end for detecting the electromagnetic radiation collected by the second fiber optic strand distal end.

8. The optical microprobe of claim 7, further comprising an analyzer for determining the intensity of electromagnetic radiation at a wavelength or wavelength range corresponding to the wavelength absorbed by a blood clot.

9. The optical microprobe of claim 8, wherein the wavelength range is selected from between about 600 nm and 1000 nm.

10. The optical microprobe of claim 8, wherein the analyzer determines the intensity of electromagnetic radiation having a wavelength range of 660 nm to 990 nm.

11. The optical microprobe of claim 8, wherein the analyzer determines a spectral contribution due to absorption of the electromagnetic radiation by a spectral component, the spectral component selected from the group consisting of oxyhemoglobin and deoxyhemoglobin.

12. The optical microprobe of claim 1, further comprising a microdrive operably connected to the holder to provide blood clot location detection along at least an axial portion of the blood vessel.

13. The optical microprobe of claim 1, wherein the first and second optic fiber strand distal ends are capable of physical contact with the blood vessel outer wall.

14. The optical microprobe of claim 13, wherein the blood vessel has a diameter selected from the range of 0.5 mm to 2 cm.

15. The optical microprobe of claim 1, wherein the optical source generates electromagnetic radiation substantially restricted to the near infrared portion of the electromagnetic spectrum.

25. A method of determining the position of a blood clot if present in a blood vessel comprising:

a. providing the optical microprobe of claim 1;

b. positioning the optical microprobe so that the blood vessel is between the distal ends of the first and second fiber optic strands;

c. illuminating the blood vessel with electromagnetic radiation;

d. collecting the electromagnetic radiation that has passed through the blood vessel;

e. analyzing the collected electromagnetic radiation to determine whether a blood clot is present; and

f. repeating steps b-e at a different axial blood vessel location, thereby determining the position of the blood clot if present within the blood vessel.

16. A method for detecting clots in a blood vessel comprising:

a. providing a first optical fiber having one end in optical contact with the outer surface of the blood vessel and the other end in optical contact with an optical source;

b. providing a second optical fiber in optical contact with the outer surface of the blood vessel, wherein the first and second optical fibers are positioned in a diametrically-opposed configuration;

c. illuminating the blood vessel with electromagnetic radiation produced by the optical source, wherein the electromagnetic radiation comprises a wavelength that is capable of being absorbed by a blood clot within the blood vessel and at least a portion of the illuminating radiation passes through the blood vessel;

d. collecting with the second optical fiber at least a portion of the electromagnetic radiation that has passed through the blood vessel,

e. detecting from the collected electromagnetic radiation, a radiation spectrum having a wavelength between about 600 nm and 1000 nm, wherein the spectrum is sensitive to blood clots; and

f. analyzing the detected radiation to determine the presence or absence of a blood clot.

17. The method of claim 16, wherein the analyzing step further comprises determining the spectrum over a wavelength range of between 650 nm and 980 nm.

18. The method of claim 16, wherein the analyzer compares the spectrum of the detected radiation with a standard blood clot spectrum, wherein the standard blood clot spectrum is obtained from an in vitro blood clot.

19. The method of claim 16, wherein the analyzing step further comprises determining a spectral contribution of a one or more spectral components selected from the group consisting of oxyhemoglobin and deoxyhemoglobin.

20. The method of claim 19, wherein the blood clot is detected by measuring a rate of change or a total change of the spectral contribution of the one or more spectral components and comparing the measured rate of change or total change to a baseline value.

21. The method of claim 16 further comprising detecting from the spectrum one or more blood parameters selected from oxyhemoglobin, deoxyhemoglobin and total hemoglobin.

22. The method of claim 16 wherein the blood vessel has a length, said method further comprising:

a. moving the optical fibers along at least a portion of the blood vessel length; and

b. obtaining a radiation spectrum along at least a portion of the blood vessel length, thereby determining the location of the blood clot.

23. The method of claim 16, wherein the method is carried out before or during a surgical procedure.

24. The method of claim 23, wherein the surgical procedure is selected from the group consisting of:

a. brain aneurysm repair;

b. ischemic stroke repair;

c. arteriovenous malformation repair;

d. peripheral artery disease repair;

e. reconstructive plastic surgery;

f. moyamoya disease repair;

g. vascular stent insertion;

h. vascular stent removal; and

i. bypass anastomoses for revascularization.